Skip to Main Content

This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.

This is a test.

Clonal hematopoiesis as a biomarker of poor prognosis in high-grade serous ovarian cancer

This is a test.

Adapting the Genetics Adviser digital app to support cascade testing

This is a test.

Uncovering targetable interactions of ovarian cancer cells

This is a test.

Prevalence and Experience of Traumatic Stress in Patients with Newly Diagnosed and Recurrent Advanced Ovarian Cancer

This is a test.

Phase II clinical trial of CX5461 at the time of disease progression on a PARP inhibitor

This is a test.

Re-VOLVE trial: using genomics to make treatment decisions after a PARP inhibitor